MNAT1 promotes proliferation and the chemo-resistance of osteosarcoma cell to cisplatin through regulating PI3K/Akt/mTOR pathway
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1471-2407
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
MNAT1 promotes proliferation and the chemo-resistance of osteosarcoma cell to cisplatin through regulating PI3K/Akt/mTOR pathway ; volume:20 ; number:1 ; day:3 ; month:12 ; year:2020 ; pages:1-12 ; date:12.2020
BMC cancer ; 20, Heft 1 (3.12.2020), 1-12, 12.2020
- Creator
-
Qiu, Chensheng
Su, Weiliang
Shen, Nana
Qi, Xiaoying
Wu, Xiaolin
Wang, Kai
Li, Lin
Guo, Zhu
Tao, Hao
Wang, Guanrong
Chen, Bohua
Xiang, Hongfei
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1186/s12885-020-07687-3
- URN
-
urn:nbn:de:101:1-2021011219155658775712
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:31 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Qiu, Chensheng
- Su, Weiliang
- Shen, Nana
- Qi, Xiaoying
- Wu, Xiaolin
- Wang, Kai
- Li, Lin
- Guo, Zhu
- Tao, Hao
- Wang, Guanrong
- Chen, Bohua
- Xiang, Hongfei
- SpringerLink (Online service)
Other Objects (12)
Interaction of ncRNAs and the PI3K/AKT/mTOR pathway: Implications for osteosarcoma
Enhanced Stim1 expression is associated with acquired chemo-resistance of cisplatin in osteosarcoma cells
Chitosan oligosaccharide suppresses osteosarcoma malignancy by inhibiting CEMIP via the PI3K/AKT/mTOR pathway
SLC38A5 suppresses ferroptosis through glutamine-mediated activation of the PI3K/AKT/mTOR signaling in osteosarcoma
ZIP10 drives osteosarcoma proliferation and chemoresistance through ITGA10-mediated activation of the PI3K/AKT pathway
C2orf40 inhibits metastasis and regulates chemo-resistance and radio-resistance of nasopharyngeal carcinoma cells by influencing cell cycle and activating the PI3K/AKT/mTOR signaling pathway
Schisandrin B Inhibits Osteosarcoma Cell Proliferation and Promotes Apoptosis Through PI3K/AKT/mTOR Pathway Mediated Autophagy
RILP inhibits tumor progression in osteosarcoma via Grb10-mediated inhibition of the PI3K/AKT/mTOR pathway
LMTK3 confers chemo-resistance in breast cancer
Correction: Schisandrin B Inhibits Osteosarcoma Cell Proliferation and Promotes Apoptosis Through PI3K/AKT/mTOR Pathway Mediated Autophagy
Targeting the PI3K/AKT/MTOR pathway in KSHV-associated cancers
DDRGK1 Enhances Osteosarcoma Chemoresistance via Inhibiting KEAP1‐Mediated NRF2 Ubiquitination
Interaction of ncRNAs and the PI3K/AKT/mTOR pathway: Implications for osteosarcoma
Enhanced Stim1 expression is associated with acquired chemo-resistance of cisplatin in osteosarcoma cells
Chitosan oligosaccharide suppresses osteosarcoma malignancy by inhibiting CEMIP via the PI3K/AKT/mTOR pathway
SLC38A5 suppresses ferroptosis through glutamine-mediated activation of the PI3K/AKT/mTOR signaling in osteosarcoma
ZIP10 drives osteosarcoma proliferation and chemoresistance through ITGA10-mediated activation of the PI3K/AKT pathway
C2orf40 inhibits metastasis and regulates chemo-resistance and radio-resistance of nasopharyngeal carcinoma cells by influencing cell cycle and activating the PI3K/AKT/mTOR signaling pathway
Schisandrin B Inhibits Osteosarcoma Cell Proliferation and Promotes Apoptosis Through PI3K/AKT/mTOR Pathway Mediated Autophagy
RILP inhibits tumor progression in osteosarcoma via Grb10-mediated inhibition of the PI3K/AKT/mTOR pathway
LMTK3 confers chemo-resistance in breast cancer
Correction: Schisandrin B Inhibits Osteosarcoma Cell Proliferation and Promotes Apoptosis Through PI3K/AKT/mTOR Pathway Mediated Autophagy
Targeting the PI3K/AKT/MTOR pathway in KSHV-associated cancers
DDRGK1 Enhances Osteosarcoma Chemoresistance via Inhibiting KEAP1‐Mediated NRF2 Ubiquitination
Interaction of ncRNAs and the PI3K/AKT/mTOR pathway: Implications for osteosarcoma
Enhanced Stim1 expression is associated with acquired chemo-resistance of cisplatin in osteosarcoma cells
Chitosan oligosaccharide suppresses osteosarcoma malignancy by inhibiting CEMIP via the PI3K/AKT/mTOR pathway
SLC38A5 suppresses ferroptosis through glutamine-mediated activation of the PI3K/AKT/mTOR signaling in osteosarcoma
ZIP10 drives osteosarcoma proliferation and chemoresistance through ITGA10-mediated activation of the PI3K/AKT pathway
C2orf40 inhibits metastasis and regulates chemo-resistance and radio-resistance of nasopharyngeal carcinoma cells by influencing cell cycle and activating the PI3K/AKT/mTOR signaling pathway
Schisandrin B Inhibits Osteosarcoma Cell Proliferation and Promotes Apoptosis Through PI3K/AKT/mTOR Pathway Mediated Autophagy
RILP inhibits tumor progression in osteosarcoma via Grb10-mediated inhibition of the PI3K/AKT/mTOR pathway
LMTK3 confers chemo-resistance in breast cancer
Correction: Schisandrin B Inhibits Osteosarcoma Cell Proliferation and Promotes Apoptosis Through PI3K/AKT/mTOR Pathway Mediated Autophagy
Targeting the PI3K/AKT/MTOR pathway in KSHV-associated cancers